NCT05956964

Brief Summary

The goal of this trial is to learn about how restricted sleep and not bearing weight on the leg affects muscle strength and posture control. Participants will walk exclusively on one leg, sleep at differing intervals, and complete posture tests, muscle strength tests, and muscle imaging. Researchers will compare adequate sleep and restricted sleep to see if muscle strength and posture are affected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 24, 2023

Completed
17 days until next milestone

Study Start

First participant enrolled

August 10, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2025

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

June 17, 2026

Completed
Last Updated

June 17, 2026

Status Verified

May 1, 2026

Enrollment Period

1.6 years

First QC Date

July 3, 2023

Results QC Date

April 14, 2026

Last Update Submit

June 16, 2026

Conditions

Keywords

sleep restrictionspaceflightunweightingposture

Outcome Measures

Primary Outcomes (4)

  • Change in Percentage in Interpolated Twitch Torque of the Loaded and Unloaded Leg

    Subjects will sit upright in an isokinetic dynamometer with the knee at 60° flexion. Gel electrode pads will be placed over the femoral nerve and just proximal to the patellar tendon. Square wave, constant current, doublet pulses from an electrical stimulator will be used to evoke twitches prior to, during, and following a maximal voluntary isometric contraction (MVIC). Twitch torque will be measured in Newton-meters (Nm). Outcome data are reported as the percentage change in voluntary activation from baseline.

    Baseline and study completion, approximately 14 days

  • Percent Change in Single Leg Stand (SLS)

    Balance will be assessed using a dual force plate system. Participants will be asked to stand on one leg and maintain their balance for 15 seconds. Specific outcome measures include percentage change in center of pressure 95% ellipse area (sq. mm) compared to baseline.

    Baseline and study completion, approximately 14 days

  • Muscle Volume

    Diffusion Tensor Imaging (DTI) will be used to quantify muscle volume of the loaded and unloaded leg. Subjects will lay supine, and slightly flex the knee (\~10°) to elongate and straighten the quadriceps. A spine array coil will be placed on the MR-scanner table and a flexible body coil wrapped around the upper thigh and centered over mid-thigh of the dominant leg. Multiple images will be taken. DSI Studio program will be used to analyze raw images.

    Post-intervention, approximately 14 days after start of study

  • Percent Change in Center of Pressure Velocity During Single Leg Stance

    Balance will be assessed using a dual force plate system. Participants will stand on one leg on a stable force deck for 15 seconds. The mean Center of Pressure (CoP) velocity will be measured in millimeters per second (mm/s) for loaded and unloaded limbs. Outcomes are reported as the percentage change in mean velocity compared to pre-intervention.

    Baseline and study completion, approximately 14 days

Study Arms (2)

Sleep Restriction (SR)

EXPERIMENTAL

The research team will provide participants with a pair of shoes to wear throughout the study. The right shoe will be modified to include a 5cm (approximately 2") rocker-style platform which will keep the left leg suspended during walking. Participants will also be provided with a pair of short crutches to assist with walking. Participants in the SR group will sleep only 5 hours for three consecutive nights.

Behavioral: Sleep Restriction

Sleep Adequate (SA)

ACTIVE COMPARATOR

The research team will provide participants with a pair of shoes to wear throughout the study. The right shoe will be modified to include a 5cm (approximately 2") rocker-style platform which will keep the left leg suspended during walking. Participants will also be provided with a pair of short crutches to assist with walking. Participants in the SA group will sleep for 9 hours for three consecutive nights.

Behavioral: Sleep Adequate

Interventions

Sleep AdequateBEHAVIORAL

9 hours of sleep for 3 days

Sleep Adequate (SA)

5 hours of sleep for 3 days

Sleep Restriction (SR)

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18 and 50 years
  • Regularly engaging in aerobic exercise (\> 150min/wk) and resistance exercise (\>1 time per week) for the past 12 months
  • Regularly sleep at least 7 hours per night

You may not qualify if:

  • Age \< 18 or \> 50 years
  • Height between \<150 (F) or \<170 (M) and \> 190 cm (both sexes)
  • Waist circumference \< 55cm or \> 90cm (F) and \< 75cm or \> 100cm (M)
  • Body mass index \< 18.5 or \> 27.5
  • Do not regularly sleep between 7 and 9 hours each night
  • Have a known sleep disorder
  • Not regularly engaging in exercise for previous 12 months
  • Blood clotting disorder
  • Heart arrhythmia
  • Implanted device which could negatively be affected by electrical impulse or strong magnetic field such as pacemaker, internal defibrillator, or cochlear implant
  • Diagnosed cardiovascular, pulmonary, renal, or metabolic disease
  • Pregnancy (within previous 6 months)
  • Oral contraceptive use (within previous three months)
  • High resting blood pressure (\>140 systolic and/or \> 90 diastolic)
  • Currently or previously undergone gender-affirming therapy (hormone therapy or sexual reassignment surgery)
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40506, United States

Location

MeSH Terms

Conditions

Muscle WeaknessParasomnias

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsSleep Wake DisordersMental Disorders

Results Point of Contact

Title
Dr. Lance Bollinger
Organization
University of Kentucky

Study Officials

  • Lance Bollinger, PhD

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Subjects will be randomized to different arms via a matched-pairs design using the following criteria: age, sex, and race. Within each arm, the loaded limb will serve as an internal control to assess effects of unloading.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 3, 2023

First Posted

July 24, 2023

Study Start

August 10, 2023

Primary Completion

March 14, 2025

Study Completion

March 14, 2025

Last Updated

June 17, 2026

Results First Posted

June 17, 2026

Record last verified: 2026-05

Locations